Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 861

PDF Downloaded: 383


Get Permission Girish B S, Johns, Meghana C S, Rakshitha H R, and Nekkanti: A review on the impact of analgesic use during pregnancy on stillbirth


Introduction

World Health Organization (WHO) defines stillbirth as foetal death after 28 weeks of pregnancy, but before or during birth.1 Stillbirth is a tragic complication of the pregnancy which is associated with emotional, social and economic disturbances which is crucial to address the issue prior and to assess at each step of the pregnancy to avoid this complication.

Stillbirth can be a result of many causes like obesity, smoking, advanced maternal age (over 40), multiparity, hypertensive disorders of pregnancy (HDP), gestational diabetes, some ethnic race especially black women (because of no proper perinatal care) and others like inappropriate gestational periods, infections, thrombophilia etc.2, 3, 4, 5, 6, 7, 8 But in recent years’ usage of drugs in pregnancy has been increased dramatically, globally it is estimated that 23%–85% of women use one or more types of prescribed medications during pregnancy.9, 10 Prior to a new medicine being released into the market, the company seldom ever conducts studies on pregnant mothers to ascertain the drug's effects on the foetus.11 As a result, safety profile for most of the drugs are poorly established.

The most recent statistics showed that there were 13.9 stillbirths per 1,000 live births worldwide in 2019.12 This translates to one stillborn child every 16 seconds, or one in every 72 births overall. However, given that stillbirths are frequently underreported, this figure may be misinterpreted. The perinatal mortality rate in India currently is 36 deaths per 1,000 pregnancies.13 According to Government’s Annual report on the registration of Birth and Death reports act, 1969 stated that, in Karnataka 3.48% is the stillbirth rate in 2020.14 In order to alleviate the burden of stillbirth, Government of India initiated 'The India Newborn Action Plan' in 2014, with the goal of lowering the rate of stillbirth by one-third nearing to 2025.15

As a thumb rule, each prescription has its own set of advantages and hazards, which may directly or indirectly affect the foetal health. Drugs like anticancer drugs, antiepileptic drugs, antipsychotics, analgesics cause stillbirth. In general, drug exposure was associated with the two-fold increased risk of stillbirth in pregnancy.16 Usage of OTC during pregnancy has been increased,17 which risks the foetus health. Painkillers are often used to self-medicate without the supervision of a medical professional.18 In the current review, the risk of stillbirth on usage of analgesics during pregnancy is underlined. 

Discussion

Factors influencing the risk of stillbirth:

Stillbirth can be caused by a variety of factors, which account for foeto-maternal mortality; nevertheless, documenting the reason for stillbirth is a stumbling block that leads to the notion that the cause of stillbirth is unclear.19 Some of the factors are discussed hereafter. 

Advanced maternal age

In most industrialized nations, the average mother age during delivery has increased in recent decades.20 The risk of stillbirth during pregnancy is three times higher in women of advanced maternal age i.e. beyond the age of 40, with or without any medical issues.21 The combination of age and gestational week results in strain on expectant mothers. Conventionally, stillbirth rates are high during the early gestational week (20-23 weeks), decline between 39 and 41 weeks of gestation and then subsequently rises at 42 weeks and beyond.22 

Studies showed that placental abnormal phenotype was prevalent in women aged 40 and above, in addition to the reduction in food intake that comes 8with aging in women. Ageing is also related with increased risk of elevated reactive oxygen species, inflammatory markers that cause oxidative stress, and tissue functio laesa that may be a factor in placental abnormalities, which exhibits as increased placental weight, altered utero-placental vascular function and decreased placental efficiency attributing to increased risk of stillbirth.23

Obesity

Women who are pregnant should look for both themselves and the developing foetus. High Body Mass Index (BMI) adds significantly to any medical problem; bearing a child will be a health burden for those with excessive body mass. Obesity defined as BMI > 30kg/m2, doubles the chance of stillbirth.24 Corpulence increases the length of the umbilical cord accounting to hyper coiling, which increases the risk of cord entanglement, clogging of the umbilical cord, and umbilical knot around the foetus, reducing the blood flow and resulting in placental insufficiency, which causes foetal growth restriction and stillbirth.25

Increased BMI may be a result of inheritance or a sedentary lifestyle. In order to minimize stillbirth, pregnant women should maintain a good height to body weight ratio.

Social habits

Physical and emotional stress along with lack of education and social awareness would make one dependent on social vices like chewing tobacco, smoking and drinking alcohol. 

Smoking and chewing tobacco increases the incidence of stillbirth by 14% and has its own impact on the health of the mother and developing foetus before, after, and even during pregnancy.26, 27 Cigarette smoking and alcohol consumption causes narrowing of placental vessels and consequently impairing blood supply to foetus, in addition to this, reduces foetal oxygenation causing complex cascade resulting in shock and foetal death.26, 28

Socio-economic status

According to National Institute for Transforming India (NITI) Aayog, 25.01% of India’s population are considered as multidimensionally poor in 2021,29 which contributes to one-fourth of Indian population suggesting lack of education, awareness, poor antenatal care contributing to majority of pregnancy-related complications. A comprehensive evaluation of research from developing nations found that poor socioeconomic position of pregnant women was strongly related with stillbirth, with an attributable percentage ranging from 2% to 75% of the population.30 In addition to all these, lack of woman’s autonomy in terms of decision making may majorly affect the health of the mother and foetus contributing to maternal and foetal complications including stillbirth.31 

Comorbidities

Age, low educational attainment, and socioeconomic standing all have an effect on an individual's overall health, leading to several chronic conditions that can end in miscarriage. 

Hypertensive disorders of pregnancy (HDP) like preeclampsia and eclampsia have resulted in 15% of perinatal foetal mortality, similarly pre-gestational diabetes and Gestational diabetes mellitus increases the risk of stillbirth by 4-5 folds by causing foetal anaerobic respiration, shock and death. India being the World Diabetes Capital, Indian pregnant women are at high risk of stillbirth.32, 33, 34, 35, 36 In addition to this, anaemia by default reduces placental oxygenation resulting in hypoxic environment attributing to stillbirth.37 

Conditions like Polycystic Ovarian Disorder (PCOD), Placenta Previa, Abruptio Placentae, oligohydramnios, infections etc causes morphological or pathological changes leading to malformed placenta which results in abnormal implantation, foetal growth restriction, placental insufficiency, necrotic placenta contributing to stillbirth.38, 39, 40, 41 

Drug use during pregnancy

Pregnancy is a unique physiological and psychological state, where the pharmacology of drugs is affected by changes in body physiology throughout time, which is of primary concern.42 Some of the drugs can cross placenta and reach developing foetus which can cause potential harm due to physiological adaptation in pregnant women. The drugs, by default, possesses inbuilt harm in pregnancy which was witnessed by the thalidomide and diethylstilboestrol catastrophe.43 These tragedies have led to more serious concerns, the Food and Drug Administration (FDA) established stringent norms on the use of drugs during pregnancy. Thereby, FDA classifies the drugs based on their teratogenic activity.42

Table 1

FDA classification of drugs used during pregnancy

Categories

Description

Example

A

Adequate studies on pregnant women indicated no foetal risk

Vitamin B, C, D, E and folic acid, thyroxin etc.

B

Animal studies have showed no evidence of harm to the foetus, but lack of studies in pregnant women

Acetaminophen, Phenacetin etc.

C

Animal studies have shown adverse effect or no animal studies are conducted and no adequate studies in pregnant women

Aspirin, Gentamicin, antimalarial etc.

D

Studies showed risk to foetus, but benefit may outweigh the risk

Streptomycin, Tetracycline etc.

X

Studies showed evident risk to the foetus and use of the drug is contraindicated in pregnant women.

Estrogen, Norethindrone Etc.

Some women become pregnant with pre-existing medical issues and few others develop novel medical conditions during the course of pregnancy that necessitate therapeutic intervention. Failure to address these issues has an impact on the health of both the expectant mother and the growing baby.44 According to a study conducted by Sharma R and co-authors, around 8% of awaiting mothers require therapeutic intervention because of prevailing medical issues and pregnancy-related complications.45 Considering the mother and foetal health; vitamins, minerals, iron and other dietary supplements are essential. 

Drug use during pregnancy plays a pivotal role in ameliorating the mother's health and well being; nevertheless, for drug used to be successful, it must be non-toxic, effective, and should be rationally used. Primary factors of irrational medication usage include ease of access, feelings of improvement, underestimation of drug toxicity, unethical advertising, cost-driven attitude, incorrect perceptions of drug side effects, lack of adequate drug education by the prescriber, a lack of regulatory control system, etc.46 The outcome of irrational use of drugs is exhibited as maternal and foetal complications owing to maternal as well as foetal death.

As cited previously, the safety of pharmaceuticals in pregnancy is not well established, and data indicates that Over-The-Counter (OTC) and prescription drug usage is widespread throughout pregnancy, with 2-3% of drug use resulting in birth abnormalities.42 OTC medications are cheap, provide accentuated symptomatic relief which makes a pregnant woman to rely on OTC, thus promoting self-medication without being aware of risk. This had promoted pregnant women to go beyond OTC range that includes ‘Schedule H’ drugs being dispensed irrationally which are categorised under prescription drugs.47, 48 The majority of antibiotics belong within the schedule H group of medications that are arbitrarily prescribed and used during pregnancy which could attack the mother's host cells, endangering her health and forcing her to ingest more and more drugs, perhaps leading to stillbirth.

Pregnancy-related irrational medication use has grown in developing nations like India as a result of drug dispensing without a prescription, distributing by non-pharmacists, and dispensing through a third party.49 Analgesics, antipyretics, cough and nasal decongestants, antihistamines, and other drugs are available over-the-counter. Antibiotics, opioid analgesics, antihypertensive, antianginal, antipsychotic, and other medications on prescription are included.

Drug use during pregnancy will have an impact on the foetus, either directly or indirectly, causing harm, aberrant development, and even death. They also impair the placental function by causing placental insufficiency, and few results in preterm uterine contraction injuring the foetus contributing to various pregnancy-related complications including stillbirth.42

Analgesic use in pregnancy

Many circumstances might drive a pregnant woman to use analgesics; for example, drastic changes in human physiology during pregnancy produce discomfort, which is majorly perceived as pain.

Figure 1

Classification of analgesics

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/f69a9424-9bd4-4927-b0fb-00e5b187a6d6image1.jpeg

Non-opioid analgesics include Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), such as aspirin, ibuprofen, diclofenac, and naproxen, as well as paracetamol. These analgesics are available over-the-counter, allowing easy access owing to arbitrary use. Due to unavoidable stressful commitments, pregnant women frequently use a lot of over-the-counter painkillers to manage their discomfort, unknowingly endangering the unborn child's health. To minimise pregnancy-related issues, the use of NSAIDS as analgesics is not suggested in pregnancy unless required and prescribed by a medical practitioner, and should be avoided beyond the gestational age of 30 weeks. While certain analgesics, such as acetaminophen (paracetamol), are safe to take throughout pregnancy.50

In the US, 2-4% of pregnancies involved at least one opioid analgesic for pain, making the use of opioids during pregnancy a severe health risk.51 Opioids are renowned for their teratogenic effects, which pose serious health risks to both the mother and the foetus and result in issues with pregnancy. Morphine, pethidine, codeine, methadone, buprenorphine, and fentanyl are few examples of opioid analgesics.51

Mechanism of analgesics causing stillbirth

Figure 2

Mechanism involved in analgesic-induced stillbirth

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/f69a9424-9bd4-4927-b0fb-00e5b187a6d6image2.jpeg

Non-opioid analgesic

During pregnancy, the increased plasma volume, cardiac output and glomerular filtration rate changes the pattern of drug absorption, thus increasing the bioavailability of free drug flowing in the circulation of mother with features of lipid solubility and low molecular weight making it simple for these free drugs to cross the placenta allowing the entry into foetal circulation which exhibits some hazardous effects. Drugs that belongs to the above category are aspirin, ibuprofen, naproxen and acetaminophen.52

NSAIDs are cyclooxygenase enzyme inhibitors that are widely used by 19% of the population for their analgesic, antipyretic, and anti-inflammatory properties. NSAIDS are often used in the first trimester and are generally avoided in the third trimester owing to adverse effects.53

The last three months of pregnancy are the most susceptible period, as the body gradually adapts to the change as the foetus develops. NSAIDS easily pass through the placenta, and inhibition of prostanoid action may result in miscarriage. After passing through the placental barrier, they enter the foetal circulation, causing kidney injury since the developing kidneys are unable to handle the foreign substance. This causes the placenta to have very little amniotic fluid, which leads to oligohydramnios, which can cause 2 cord injuries and foetal mortality due to insufficient nutritional supply.54 (Figure 2) According a cohort study conducted by Aikaterini Zafeiri et al., on singleton pregnancies showed 405 stillbirths out of 43998 pregnant women who have consumed at least one over-the-counter analgesics.50

Opioid analgesic

Opioid use during pregnancy has been connected to a number of obstetric and perinatal problems. Pregnancies exposed to prenatal opioid in the first and second trimesters have an increased risk of stillbirth.51 The biggest danger with opioid usage is dependency, and most women hide their opioid use for a variety of reasons, one of which is a sense of improvement. In the idea of opioid analgesics, the debate between "usage" and "abuse" persists.

When opioids are taken during pregnancy, they penetrate the placenta and enter the growing foetus's system, where they pass the blood brain barrier, causing respiratory distress, foetal growth limitation, and foetal death.55 On the other hand, it also results in placental abruption by causing hypoxia and vasoconstriction of placental bed. Some of the opioid like cocaine can result in early uterine contraction leading to foetal injury and death.56 A study conducted by Brogly et al. showed a statistically significant association between the occurrence of stillbirth and opioid exposure.51

Conclusion

Analgesics are usually blindfolded as safe for the use during pregnancy, but they do carry potential risk such as stillbirth, especially with the use in the second and third trimester. The irrational use of analgesics during pregnancy is high in India without the knowledge of risk attributed by the drugs. Hence, it is of paramount importance to promote the rational usage of analgesics, which can be attained either by educating the pregnant woman about foetal risks and/or by employing a registered pharmacist who can ensure dispensing of analgesics with prior medical authorization.

Source of Funding

None.

Conflict of Interest

None.

References

1 

Stillbirth [Internet]https://www.who.int/health-topics/stillbirth#tab=tab_1[cited 1 Aug 2022]

2 

S Carmichael Y Blumenfeld J Mayo E Wei J Gould D Stevenson Prepregnancy Obesity and Risks of StillbirthPLoS One20151010e0138549

3 

E Raymond S Cnattingius JL Kiely Effects of maternal age, parity, and smoking on the risk of stillbirthBr J Obstet Gynaecol199410143016

4 

TA Mills T Lavender Advanced maternal age Obstet Gynaecol Reprod Medi201121410711

5 

R Fretts Stillbirth Epidemiology, Risk Factors, and Opportunities for Stillbirth PreventionClin Obstet Gynecol201053358896

6 

KJ Gibbins RM Silver H Pinar UM Reddy CB Parker V Thorsten Stillbirth, hypertensive disorders of pregnancy, and placental pathologyPlacenta201643618

7 

R Starikov D Dudley UM Reddy Stillbirth in the pregnancy complicated by diabetesCurr Diab Rep201515311

8 

G Smith R Fretts StillbirthLancet20073709600171525

9 

M Gendron B Martin D Oraichi A Bérard Health Care Providers’ Requests To Teratogen Information Services On Medication Use During Pregnancy And LactationEur J Clin Pharmacol200965552331

10 

A Mitchell S Gilboa M Werler K Kelley C Louik S Hernández-Díaz Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008Am J Obstet Gynecol2011205151

11 

G Koren A Pastuszak S Ito Drugs In PregnancyN Engl J Med199833816112837

12 

Stillbirths and stillbirth rates - UNICEF DATA [Internet]https://data.unicef.org/topic/child-survival/stillbirths/[cited 12 Aug 2022]

13 

Health and Family Welfare Statistics in India 2019-20 [Internet]2021https://main.mohfw.gov.in/newshighlights-19[cited 15 Aug 2022]

14 

Annual Report on the Registration of Births and Deaths act, 1969 [Internet]. Government of Karnataka, 2020https://ejanma.karnataka.gov.in/Documents/CRS/CRS-2020.pdf[cited 15 Aug 2022]

15 

M Roy Mitigating The Stillbirth Challenge In IndiaLancet2016387100321995

16 

E Sevene A Bardají A Mariano S Machevo E Ayala B Sigaúque Drug Exposure And Pregnancy Outcome In MozambiquePediatric Drugs2012141439

17 

A Lupattelli O Spigset M Twigg K Zagorodnikova A Mårdby M Moretti Medication use in pregnancy: a cross-sectional, multinational web-based studyBMJ Open201442e004365

18 

S Hultzsch W Paulus S Padberg A Fietz C Schaefer K Dathe First trimester naproxen exposure and outcome of pregnancy - A German case seriesReprod Toxicol2021103517

19 

S Cnattingius O Stephansson The epidemiology of stillbirthSemin Perinatol20022612530

20 

L Huang R Sauve N Birkett D Fergusson CV Walraven Maternal Age And Risk Of Stillbirth: A Systematic ReviewCMAJ2008178216572

21 

UM Reddy CW Ko M Willinger Maternal Age And The Risk Of Stillbirth Throughout Pregnancy In The United StatesAm J Obstet Gynecol2006195376470

22 

MF Macdorman UM Reddy RM Silver Trends in Stillbirth by Gestational Age in the United States, 2006-2012Obstet Gynecol20061266114650

23 

SC Lean AEP Heazell MR Dilworth TA Mills RL Jones Placental Dysfunction Underlies Increased Risk Of Fetal Growth Restriction And Stillbirth In Advanced Maternal Age WomenSci Rep2017719677

24 

N Penn E Oteng-Ntim L Oakley P Doyle Ethnic variation in stillbirth risk and the role of maternal obesity: analysis of routine data from a London maternity unitBMC Pregnancy Childbirth201441e004365

25 

H Åmark M Westgren M Sirotkina I Hulthén Varli M Persson N Papadogiannakis Maternal obesity and stillbirth at term; placental pathology-A case control studyPLoS One2021164e0250983

26 

T Marufu A Ahankari T Coleman S Lewis Maternal smoking and the risk of still birth: systematic review and meta-analysisBMC Public Health2015151239

27 

P Gupta S Subramoney Smokeless Tobacco Use And Risk Of StillbirthEpidemiology20061714751

28 

L Burd D Roberts M Olson H Odendaal Ethanol And The Placenta: A Review. The Journal of Maternal-Fetal &ampNeonatal Medicine2007205361375

29 

National Multidimensional Poverty Index Baseline Report Based on NFHS-4 (2021) [Internet]2021https://www.niti.gov.in/sites/default/files/2021-11/National_MPI_India-11242021.pdf

30 

E Mcclure S Saleem O Pasha RL Goldenberg Stillbirth in developing countries: a review of causes, risk factors and prevention strategiesJ Matern Fetal Neonatal Med200922318390

31 

L Sanneving N Trygg D Saxena D Mavalankar S Thomsen Inequity In India: The Case Of Maternal And Reproductive HealthGlobal Health Action201361

32 

M Basta K Hanif S Zafar A Khabazeh F Amin SS Khan Impact of Hypertensive Disorders of Pregnancy on Stillbirth and Other Perinatal Outcomes: A Multi-Center Retrospective StudyCureus2022143e22788

33 

S Mackin S Nelson J Kerssens R Wood S Wild Diabetes and pregnancy: national trends over a 15 year periodDiabetologia201861510818

34 

SK Pandey V Sharma Battling The Emerging Epidemic Of Diabetic RetinopathyIndian J Ophthalmol2018661116523

35 

T Stacey P Tennant L Mccowan E Mitchell J Budd Gestational diabetes and the risk of late stillbirth: a case-control study from England, UKBJOG2019126897382

36 

DJ Dudley Diabetic-associated stillbirth: incidence, pathophysiology, and preventionObstet Gynecol Clin North Am2007342293307

37 

M Nair M Knight S Robinson C Nelson-Piercy S Stanworth D Churchill Pathways of association between maternal haemoglobin and stillbirth: path-analysis of maternity data from two hospitals in EnglandBMJ Open201884e020149

38 

H Valgeirsdottir T Kunovac Kallak I Sundström Poromaa M Jonsson N Roos L Lindström Polycystic ovary syndrome and risk of stillbirth: a nationwide register-based studyBJOG202112813207382

39 

A Yeniel A Ergenoglu I Itil N Askar R Meseri Effect of placenta previa on fetal growth restriction and stillbirthArch Gynecol Obstet201228622958

40 

CV Ananth GS Berkowitz DA Savitz RH Lapinski Placental Abruption And Adverse Perinatal OutcomesJAMA199928217164651

41 

L Figueroa E Mcclure J Swanson R Nathan A Garces J Moore Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countriesReprod Health202017119

42 

P Sachdeva BG Patel BK Patel Drug Use In Pregnancy; A Point To Ponder!Indian J Pharm Sci200971117

43 

M W Melton Take two Aspirin or not? Risk of medication use during pregnancyMother Baby J199942532

44 

SE Andrade JH Gurwitz RL Davis KA Chan JA Finkelstein K Fortman Prescription drug use in pregnancyAm J Obstet Gynaecol2004191398407

45 

R Sharma B Kapoor U Verma Drug utilization pattern during pregnancy in North IndiaIndian J Med Sci200660727787

46 

M Vance W Millington Principles of irrational drug therapyInt J Health Serv198616335562

47 

G Shruti PK Sree YV Rao Drug use pattern of over-the-counter and alternative medications in pregnancy: A cross sectional descriptive studyNatl J Physiol, Pharm Pharmacol2015531959

48 

S Kamat P Marathe R Tripathi S Raut N Khatri Over-The-Counter Medicines: Global Perspective And Indian ScenarioJ Postgrad Med20206612834

49 

G Porter N Grills Medication Misuse In India: A Major Public Health Issue In IndiaJ Public Health (Oxf)20163821507

50 

A Zafeiri EA Raja RT Mitchell DC Hay S Bhattacharya PA Fowler Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes: cohort study of 151 141 singleton pregnanciesBMJ Open2022125e048092

51 

S Brogly M Velez M Werler W Li A Camden A Guttmann Prenatal Opioid Analgesics and the Risk of Adverse Birth OutcomesEpidemiology202132344856

52 

J Kwok E Luedecke H Hall A Murray B Auyeung Analgesic drug use in pregnancy and neurodevelopment outcomes: an umbrella reviewNeurosci Biobehav Rev2022136104607

53 

MV Gelder N Roeleveld H Nordeng Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort studyPLoS One201167e22174

54 

FDA warns of possible fetal risk linked to NSAIDs [Internet]https://www.healio.com/news/rheumatology/20201015/fda-warns-of-possible-fetal-risk-linked-to-NSAIDs[cited 17 Aug 2022]

55 

HS Fricker S Segal MD Narcotic Addiction, Pregnancy, and the NewbornAdolesc Med19781324360

56 

J Zipursky D Juurlink Opioid use in pregnancy: An emerging health crisisObstetric Medicine20201442119



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

1-6


Authors Details

Girish B S*, Joel M Johns, Meghana C S, Rakshitha H R, Vineela Nekkanti


Article History

Received : 02-09-2022

Accepted : 20-09-2022


Article Metrics


View Article As

 


Downlaod Files